← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 12, 2023Last known activity
Dec 15, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (18 distinct, 13 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Recent trials (15)
- NCT07268170Lead sponsorPhase 2/Phase 3Dec 15, 2025
- NCT07290842Lead sponsorN/ADec 8, 2025
- NCT07243119Lead sponsorPhase 4Nov 24, 2025
- NCT07243119Sponsor investigatorPhase 4Nov 24, 2025
- NCT07012629CollaboratorPhase 3Sep 1, 2025
- NCT06938789CollaboratorN/AApr 30, 2025
- NCT06667999CollaboratorPhase 4Mar 1, 2025
- NCT06418074Lead sponsorN/ASep 30, 2024
- NCT06867471Lead sponsorN/ASep 11, 2024
- NCT06551246OfficialPhase 3Jun 27, 2024
- NCT06452199CollaboratorN/AJun 10, 2024
- NCT06465576OfficialPhase 4May 27, 2024
- NCT05980858Reponsible party - principal investigatorN/AAug 31, 2023
- NCT05980858Lead sponsorN/AAug 31, 2023
- NCT05841420CollaboratorPhase 2Jun 12, 2023
Details
- Last known activity
- Dec 15, 2025